SalubrisBio (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- March 07, 2022
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $32,000,000
Company Info
- Founding Year
- 2016
- Company Description
- SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
- Market
- Cardiovascular, Oncology, Neurodegenerative Diseases
- Location
- Gaithersburg, MD, USA
- Coinvestors
- Salubris Pharmaceuticals